PFE stock today: Pfizer's stock dipped despite strong fourth-quarter earnings. Investors reacted to the company's modest 2026 outlook. Decl...

Strong Covid product sales and cost-cutting initiatives drove Pfizer's $17.76 billion in revenue in Q4, exceeding Wall Street's projections...

Revenue from Pfizer's COVID-19 vaccine and treatment, which peaked at $57 billion in 2022, are now expected to be $8 billion in 2024, a fur...

The National Medical Products Administration said Paxlovid is approved to treat adults who have mild to moderate COVID-19 and high risk of ...

Although Pfizer raised its forecast for the vaccine, developed with Germany's BioNTech SE, by $1 billion to $32 billion, the drugmaker caut...

The SEC asked the companies to conduct bioavailability and bioequivalence (BA/BE) studies and submit safety data at its meeting on Friday, ...

A total of 843,208 participants met the eligibility criteria, of whom 758,118 (90 per cent) received the booster during the 54-day study pe...

The Pfizer COVID-19 vaccine provides less immunity against Omicron than from other coronavirus variants, according to a lab study that sugg...

India is reluctant to provide such overseas indemnity but is in talks for an early resolution to facilitate the supply of the Pfizer-BioNTe...

In its response, Pfizer said that alternative dosing regimens of its vaccine had not been evaluated yet and the decision to do that resided...

"This finding can help countries make informed decisions regarding vaccine policy -- for instance, whether those previously infected should...

The panel observed that incidents of serious adverse effects such as palsy and anaphylaxis and the causality of the events with the vaccine...

Margaret Keenan, from Enniskillen, said she felt "so privileged" to receive the jab at University Hospital, Coventry. Keenan become the fir...

The firm, in its application submitted to the drug regulator, has sought permission to import the vaccine for sale and distribution in the ...

"The Government has today accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to ap...

"Today's Emergency Use Authorisation in the UK marks a historic moment in the fight against Covid-19," said Pfizer CEO Albert Bourla.

It said the updated analysis was based on 8,000 trial participants. Pfizer said in a previous analysis that 3.7 per cent of 6,000 volunteer...